Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | VIR |
---|---|---|
09:32 ET | 8712 | 9.05 |
09:34 ET | 500 | 8.95 |
09:36 ET | 1574 | 8.88 |
09:38 ET | 2600 | 8.9 |
09:39 ET | 1000 | 8.905 |
09:41 ET | 4135 | 8.81 |
09:43 ET | 1900 | 8.76 |
09:45 ET | 1251 | 8.79 |
09:48 ET | 1224 | 8.79 |
09:50 ET | 3962 | 8.78 |
09:52 ET | 1985 | 8.81 |
09:54 ET | 540 | 8.8 |
09:56 ET | 300 | 8.795 |
09:57 ET | 400 | 8.785 |
09:59 ET | 190 | 8.78 |
10:01 ET | 100 | 8.785 |
10:03 ET | 2530 | 8.8 |
10:06 ET | 100 | 8.805 |
10:08 ET | 200 | 8.81 |
10:10 ET | 1300 | 8.8 |
10:12 ET | 641 | 8.825 |
10:14 ET | 900 | 8.85 |
10:15 ET | 42189 | 8.95 |
10:17 ET | 2911 | 8.94 |
10:19 ET | 924 | 8.945 |
10:21 ET | 100 | 8.955 |
10:24 ET | 2530 | 8.995 |
10:26 ET | 11152 | 8.98 |
10:28 ET | 1792 | 8.97 |
10:30 ET | 18189 | 9.02 |
10:32 ET | 9859 | 9.06 |
10:33 ET | 3251 | 9.075 |
10:35 ET | 1212 | 9.08 |
10:37 ET | 1800 | 9.085 |
10:39 ET | 1277 | 9.09 |
10:42 ET | 4654 | 9.115 |
10:44 ET | 36165 | 9.1 |
10:46 ET | 2849 | 9.115 |
10:48 ET | 1737 | 9.12 |
10:50 ET | 4709 | 9.105 |
10:51 ET | 36300 | 9.07 |
10:53 ET | 2445 | 9.07 |
10:55 ET | 19115 | 9.1204 |
10:57 ET | 2127 | 9.13 |
11:00 ET | 1440 | 9.14 |
11:02 ET | 12379 | 9.13 |
11:04 ET | 1573 | 9.135 |
11:06 ET | 1078 | 9.145 |
11:08 ET | 6579 | 9.135 |
11:09 ET | 2746 | 9.14 |
11:11 ET | 1315 | 9.13 |
11:13 ET | 550 | 9.12 |
11:15 ET | 100 | 9.12 |
11:18 ET | 974 | 9.095 |
11:20 ET | 10314 | 9.05 |
11:22 ET | 1906 | 9.04 |
11:24 ET | 720 | 9.03 |
11:27 ET | 1354 | 9 |
11:29 ET | 1300 | 9.03 |
11:31 ET | 510 | 9.04 |
11:33 ET | 330 | 9.03 |
11:36 ET | 780 | 9.01 |
11:38 ET | 250 | 9.01 |
11:40 ET | 1841 | 9.02 |
11:42 ET | 1600 | 9.025 |
11:44 ET | 400 | 9.025 |
11:45 ET | 1783 | 9.04 |
11:47 ET | 100 | 9.0399 |
11:49 ET | 900 | 9.01 |
11:51 ET | 200 | 9.0125 |
11:54 ET | 2032 | 9.015 |
11:56 ET | 1618 | 9 |
11:58 ET | 761 | 8.995 |
12:00 ET | 400 | 8.99 |
12:02 ET | 400 | 8.99 |
12:03 ET | 300 | 8.99 |
12:05 ET | 900 | 8.99 |
12:07 ET | 200 | 8.99 |
12:09 ET | 1000 | 9 |
12:12 ET | 976 | 8.995 |
12:14 ET | 200 | 8.995 |
12:16 ET | 678 | 9 |
12:18 ET | 500 | 9 |
12:20 ET | 300 | 8.99 |
12:21 ET | 405 | 9 |
12:23 ET | 1606 | 9 |
12:25 ET | 1468 | 9 |
12:27 ET | 400 | 9.02 |
12:32 ET | 500 | 9.02 |
12:34 ET | 100 | 9.025 |
12:36 ET | 100 | 9.025 |
12:38 ET | 2080 | 9.02 |
12:39 ET | 1400 | 9.03 |
12:45 ET | 2160 | 9.04 |
12:48 ET | 300 | 9.035 |
12:50 ET | 600 | 9.02 |
12:52 ET | 300 | 9.02 |
12:54 ET | 900 | 9.04 |
12:56 ET | 2100 | 9.03 |
12:57 ET | 5200 | 9.025 |
12:59 ET | 300 | 9.02 |
01:01 ET | 6260 | 9.01 |
01:03 ET | 1100 | 9.015 |
01:06 ET | 1000 | 9.02 |
01:08 ET | 200 | 9.035 |
01:10 ET | 1002 | 9.045 |
01:12 ET | 1221 | 9.07 |
01:14 ET | 400 | 9.08 |
01:15 ET | 700 | 9.07 |
01:17 ET | 837 | 9.0801 |
01:19 ET | 749 | 9.09 |
01:21 ET | 100 | 9.095 |
01:24 ET | 100 | 9.095 |
01:26 ET | 1216 | 9.1 |
01:30 ET | 3073 | 9.12 |
01:32 ET | 800 | 9.11 |
01:33 ET | 200 | 9.115 |
01:35 ET | 730 | 9.12 |
01:37 ET | 292 | 9.125 |
01:39 ET | 2890 | 9.09 |
01:42 ET | 850 | 9.0612 |
01:44 ET | 100 | 9.06 |
01:46 ET | 345 | 9.0702 |
01:48 ET | 2000 | 9.055 |
01:50 ET | 3089 | 9.075 |
01:51 ET | 1900 | 9.055 |
01:53 ET | 300 | 9.05 |
01:55 ET | 1062 | 9.06 |
01:57 ET | 200 | 9.07 |
02:00 ET | 992 | 9.05 |
02:02 ET | 3086 | 9.025 |
02:04 ET | 2662 | 9.0401 |
02:08 ET | 100 | 9.06 |
02:09 ET | 3280 | 9.045 |
02:11 ET | 2101 | 9.0403 |
02:13 ET | 900 | 9.0101 |
02:15 ET | 1600 | 9 |
02:18 ET | 162 | 8.99 |
02:20 ET | 801 | 8.98 |
02:22 ET | 427 | 8.99 |
02:24 ET | 100 | 8.97 |
02:26 ET | 100 | 8.975 |
02:27 ET | 665 | 8.97 |
02:29 ET | 2135 | 8.975 |
02:31 ET | 1600 | 8.99 |
02:33 ET | 1900 | 9.01 |
02:36 ET | 330 | 9.005 |
02:38 ET | 300 | 9.01 |
02:40 ET | 400 | 9.015 |
02:42 ET | 539 | 9.02 |
02:45 ET | 1103 | 9.04 |
02:47 ET | 1885 | 9.045 |
02:49 ET | 1621 | 9.06 |
02:51 ET | 656 | 9.08 |
02:54 ET | 3489 | 9.1 |
02:56 ET | 1737 | 9.09 |
02:58 ET | 11006 | 9.08 |
03:00 ET | 600 | 9.085 |
03:02 ET | 9231 | 9.08 |
03:03 ET | 2449 | 9.085 |
03:07 ET | 5122 | 9.105 |
03:09 ET | 500 | 9.1 |
03:12 ET | 900 | 9.1 |
03:14 ET | 1695 | 9.105 |
03:16 ET | 2434 | 9.09 |
03:18 ET | 100 | 9.09 |
03:20 ET | 3209 | 9.08 |
03:21 ET | 4520 | 9.115 |
03:23 ET | 1100 | 9.0892 |
03:25 ET | 1026 | 9.09 |
03:27 ET | 1430 | 9.1 |
03:30 ET | 4914 | 9.095 |
03:32 ET | 5668 | 9.095 |
03:34 ET | 4115 | 9.085 |
03:36 ET | 4859 | 9.06 |
03:38 ET | 2168 | 9.06 |
03:39 ET | 2859 | 9.055 |
03:41 ET | 5729 | 9.0585 |
03:43 ET | 5057 | 9.095 |
03:45 ET | 3813 | 9.095 |
03:48 ET | 5149 | 9.095 |
03:50 ET | 9289 | 9.105 |
03:52 ET | 14360 | 9.13 |
03:54 ET | 14204 | 9.13 |
03:56 ET | 16533 | 9.17 |
03:57 ET | 67725 | 9.175 |
03:59 ET | 58199 | 9.18 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Vir Biotechnology Inc | 1.2B | -2.0x | --- |
Prothena Corporation PLC | 1.2B | -7.9x | --- |
Immatics NV | 1.1B | -8.5x | --- |
Arcutis Biotherapeutics Inc | 1.0B | -2.2x | --- |
Abcellera Biologics Inc | 1.1B | -7.6x | --- |
MacroGenics Inc | 972.8M | -99.8x | --- |
Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.2B |
---|---|
Revenue (TTM) | $86.2M |
Shares Outstanding | 135.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.46 |
EPS | $-4.59 |
Book Value | $11.80 |
P/E Ratio | -2.0x |
Price/Sales (TTM) | 13.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -794.04% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.